The global CD Antigen Cancer Therapy Market is valued at USD 27.5 Billion in 2024 and is projected to reach a value of USD 54 ...

Although CAR T-cell therapies have reached significant clinical success in hematological malignancies, their utility in solid tumors remains limited. One of the main challenges is the scarcity of ...

American Indian and Black patients were 23% less likely to have an elevated cancer antigen (CA)-125 level at diagnosis. Current CA-125 thresholds may miss racially and ethnically diverse patients ...

A new at-home saliva test for prostate cancer could outperform current testing methods, a new study suggests. Researchers ...

Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Now, research ...

Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally ...

PGV001, a personalized cancer vaccine, induced immune responses across various cancer types like breast and urothelial cancer ...

Epsilogen’s earlier stage pipeline also features a number of other IgE antibody candidates targeting a variety of tumour antigens. Epsilogen is the world’s leading pan-isotype antibody ...

triggering an antigen-specific immune response. The activated T cells migrate to tumor tissues, recognize and kill the cancer cells expressing the target antigens. In preclinical studies, EVM14 ...